Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE: 603439)
Health Care · Pharmaceuticals · CN
CN¥12.55
-4.78% today · +1.5% 1Y
Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE: 603439) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $758.35M and employs 1,887 people.
Over the last twelve months the share price has gained 1.5%, trading between 9.51 and 17.46.
Tweenvest scores Guizhou Sanli Pharmaceutical Co.,Ltd across four factors: quality 72/100, value 50/100, growth 66/100, dividend 56/100. Its strongest factor is quality.
603439 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $758.35M
- Revenue (TTM)
- $229.70M
- P/E
- —
- EPS
- 0.00
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.97
- 52-week high
- CN¥17.46
- 52-week low
- CN¥9.51
- Avg volume (3M)
- —
- Shares outstanding
- 404.74M
- Employees
- 1,887
- Next earnings
- —
About Guizhou Sanli Pharmaceutical Co.,Ltd
This pharmaceutical enterprise is dedicated to the comprehensive process of developing, manufacturing, and distributing medicinal products. Its diverse portfolio includes therapeutic solutions for children, respiratory ailments, cardiovascular and cerebrovascular disorders, digestive issues, trauma recovery, rehabilitation needs, and ophthalmic conditions. The company commenced operations in 1995 and maintains its primary base in Guiyang, China.
- ISIN
- CNE1000040B4
- Founded
- 1995
- Listed since
- Apr 28, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Teyi Pharmaceutical Group Co.,LtdSZSE: 002728 | $780.82M | CN¥10.24 | +3.33% |
| Shandong Jincheng Pharmaceutical Group Co., LtdSZSE: 300233 | $780.40M | CN¥13.78 | +1.32% |
| Center Laboratories, Inc.TPEX: 4123 | $775.56M | NT$31.35 | +0.48% |
| CHO Pharma, Inc.TPEX: 6586 | $773.05M | NT$115.50 | -0.86% |
| Heilongjiang ZBD Pharmaceutical Co., Ltd.SHSE: 603567 | $756.62M | CN¥5.40 | +2.66% |
| DongKook Pharmaceutical Co., Ltd.KOSDAQ: A086450 | $751.63M | ₩22,400.00 | -1.54% |
| Lexicon Pharmaceuticals, Inc.NasdaqCM: LXRX | $747.53M | $1.61 | -4.17% |
| Knight Therapeutics Inc.TSX: GUD | $745.60M | CA$10.83 | +4.94% |
Figures last refreshed Oct 11, 2026.